Clinical and Radiographic Outcome of a Cementless, Titanium, Plasma Spray-coated Total Hip Arthroplasty Femoral Component. Justification for Continuance of Use
Overview
Affiliations
Between 1984 and 1986, 177 nonconsecutive, primary total hip arthroplasties were performed in 150 patients using the Mallory-Head Porous femoral component (Biomet, Warsaw, IN) inserted without cement. Average time to follow-up evaluation for the entire population (including all early revisions) was 76 months (6.3 years). There were 10 revisions (6%) with an average time to revision of 50 months (4.2 years). Two revisions were for component undersizing; three revisions were for aseptic loosening; four revisions were for acetabular component failure and one revision was due to a femoral fracture secondary to trauma. At the most recent follow-up visit, the average Harris hip score for all hips increased from 41.5 before surgery to 86.8 (P < .001). Radiographic assessments yielded an average Engh fixation score of 20.7. The Kaplan-Meier survival estimate for the average time to follow-up evaluation was 0.98. Based on our patient selection criteria and excellent intermediate clinical and radiographic results, the initial design strategies of the Mallory-Head Porous femoral prosthesis have been confirmed.
Teh H, Abounouh M, Haibock P, Selvaratnam V, Ganapathy S, Graichen H J Orthop. 2024; 50:42-48.
PMID: 38162260 PMC: 10755486. DOI: 10.1016/j.jor.2023.11.068.
Batailler C, Fary C, Servien E, Lustig S PLoS One. 2018; 13(10):e0204591.
PMID: 30289882 PMC: 6173375. DOI: 10.1371/journal.pone.0204591.
Sachs D, Capobianco R, Cher D, Holt T, Gundanna M, Graven T Med Devices (Auckl). 2014; 7:299-304.
PMID: 25210479 PMC: 4155989. DOI: 10.2147/MDER.S56491.
Poor intermediate-term survival of the uncemented Optan anatomically adapted femoral component.
Heijnens L, Halma J, van Gaalen S, de Gast A Acta Orthop. 2014; 85(4):363-7.
PMID: 24954492 PMC: 4105766. DOI: 10.3109/17453674.2014.934185.
Proximally versus fully porous-coated femoral stems: a multicenter randomized trial.
MacDonald S, Rosenzweig S, Guerin J, McCalden R, Bohm E, Bourne R Clin Orthop Relat Res. 2009; 468(2):424-32.
PMID: 19777316 PMC: 2806990. DOI: 10.1007/s11999-009-1092-3.